Childhood autoimmune neurologic diseases of the central nervous system

Neurologic Clinics

Volumn 21, Issue 4, 2003, Pages 745-764

  Jones, Charlotte T ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; DEXAMETHASONE; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; METHYLPREDNISOLONE; PLACEBO; STEROID;

ACUTE DISEASE; ADOLESCENT; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; ENCEPHALOMYELITIS; FEVER; HUMAN; MULTIPLE SCLEROSIS; MYELITIS; NEUROLOGIC DISEASE; ONSET AGE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; SEIZURE; SIDE EFFECT; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0142043299     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(03)00007-0     Document Type: Review

References (83)

1. Lucas J. An account of uncommon symptoms succeeding the measles; with some additional remarks on the infection of measles and smallpox. London Medical Journal 1790;11:325.
2. Scott TFM. Postinfectious and vaccinal encephalitis. Med Clin North Am 1967;51:701-16.
3. Miller HG, Stanton JB, Gibbons JL. Para-infectious encephalomyelitis and related syndromes. J Med 1956;NS XXV(100):427-505.
4. Dale RC, de Sousa C, Choong WK, Cox TCS, Harding B, Neville BGR. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22.
5. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002;59:1224-31.
6. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-12.
7. Rust RS, Dodson W, Prensky A, et al. Classification and outcome of acute disseminated encephalomyelitis. In: Program and Abstracts of the 26th Annual Meeting of the Child Neurology Society, Phoenix. Ann Neurol 1997;42(3):491.
8. Miller HG, Evans MJ. Prognosis in acute disseminated encephalomyelitis; with a note on neuromyelitis optica. Q J Med 1953;NS XXII(87):347-79.
9. Marchioni E, Marinou-Aktipi K, Uggetti C, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 2002;249:100-4.
10. Kimura S, Nezu A, Ohtsuki N, Kobayashi T, Osaka H, Uehara S. Serial magnetic resonance imaging in children with postinfectious encephalitis. Brain Dev 1996;18:461-5.
11. Lisak RP, Behan PO, Zweiman B, Shetty T. Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis. Neurology 1974;24:560-4.
12. Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis - clinical and immunologic studies. N Engl J Med 1984;310:137-41.
13. Johnson RT. The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis 1987;155:359-64.
14. Phol-Koppe A, Burchett SK, Thiele EA, Hafler DA. Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. J Neuroimmunol 1998;91:19-27.
15. Ichiyama T, Shoji H, Kato M, et al. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur J Pediatr 2002;161:133-7.
16. Hemmer B, Cepok S, Nessler S, Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol 2002;15:227-31.
17. Stocks M. Genetics of childhood disorders: XXIX. autoimmune disorders, part 2: molecular mimicry. J Am Acad Child Adolesc Psychiatry 2001;40:977-80.
18. Khong PL, Ho HK, Cheng PW, Wong VCN, Goh W, Chan FL, Childhood acute disseminated encephalomyelitis: the role of brain and spinal cord MRI. Pediatr Radiol 2002;32:59-66.
19. Karelitz S, Eisenberg M. Measles encephalitis: evaluation of treatment with adrenocorticotropin and corticosteroids. Pediatrics 1961;27:811-8.
20. Kesselring J, Miller DH, Robb SA, et al. Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis. Brain 1990;113:291-302.
21. Ohtaki E, Murakami Y, Komori H, Yamashita Y, Matsuishi T. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pediatr Neurol 1992;8:137-9.
22. Hung KL, Liao HT, Tsai ML. Postinfectious encephalomyelitis: etiologic and diagnostic trends. J Child Neurol 2000;15:666-70.
23. Nasr JT, Andriola MR, Coyle PK. ADEM: literature review and case report of acute psychosis presentation. Pediatr Neurol 2000;22:8-18.
24. Baum PA, Barkovich AJ, Koch TK, Berg BO. Deep gray matter involvement in children with acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 1994;15:1275-83.
25. San Pedro EC, Mountz JM, Liu HG, Deutsch G. Postinfectious cerebellitis: clinical significance of Tc-99m HMPAO brain SPECT compared with M.R.I. Clin Nucl Med 1998;23:212-6.
26. Bizzi A, Ulug AM, Crawford TO, et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001;22:1125-30.
27. Allen JE. Treatment of measles encephalitis with adrenal steroids. Pediatrics 1957;20:87-91.
28. Appelbaum E, Abler C. Treatment of measles encephalitis with corticotropin. AMA Journal of Diseases of Children 1956;92:147-51.
29. Boe J, Solberg CO, Saeter T. Corticosteroid treatment for acute meningoencephalitis: a retrospective study of 346 cases. BMJ 1965;1:1094-5.
30. Pasternak JF, DeVivo DC, Prensky AL. Steroid-responsive encephalomyelitis in childhood. Neurology 1980;30:481-6.
31. Kleiman M, Brunquell P. Acute disseminated encephalomyelitis: response to intravenous immunoglobulin? J Child Neurol 1995;10:481-3.
32. Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 1996;46:1173-4.
33. Balestri P, Grosso S, Acquaviva A, Bernini M. Plasmapheresis in a child affected by acute disseminated encephalomyelitis. Brain Dev 2000;22:123-6.
34. Sriram S, Steinman L. Postinfectious and postvaccinial encephalomyelitis. Neurol Clin 1984;2:341-53.
35. Apak RA, Kose G, Anlar B, Turanh G, Topaloglu H, Ozdirim E. J Acute disseminated encephalomyelitis in childhood. Child Neurol 1999;14:198-201.
36. Alcock NS, Hoffman HL. Recurrent encephalomyelitis in childhood. Arch Dis Child 1962;37:40-4.
37. Poser CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994;36(S2):S180-93.
38. Stuve O, Zamvil SS. Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis. Curr Opin Neurol 1999;12:395-401.
39. Paty DW, Oger JJF, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180-5.
40. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
41. Khan S, Yaqub BA, Poser CM, Al Deeb SM, Bohlega S. Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia. J Neurol Neurosurg Psychiatry 1995;58:467-70.
42. Sadiq SA, Miller JR. Multiple sclerosis. In: Rowland LP, editor. Merritt's textbook of neurology. 9th edition. Baltimore: Williams & Wilkins; 1995. p. 804-25.
43. Cole GF, Stuart CA. A long perspective on childhood multiple sclerosis. Dev Med Child Neurol 1995;37:661-6.
44. Sindern E, Haas J, Stark E, Wurster U. Early onset multiple sclerosis under the age of 16: clinical and paraclinical features. Acta Neurol Scand 1992;86:280-4.
45. Ghezzi A, Deplano V, Faroni J, et al. Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler 1997;3:43-6.
46. Ruggieri M, Polizzi A, Pavone L, Grimaldi LME. Multiple sclerosis in children under 6 years of age. Neurology 1999;53:478-84.
47. Duquette P, Murray TJ, Pleines J, et al. Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr 1987;111:359-63.
48. Steinman L, Martin R, Bernard C, Conlon P, Oksenberg JR. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu Rev Neurosci 2002;25:491-505.
49. Stuerzebecher S, Martin R. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis. Neuroimaging Clin N Am 2000;10:649-68.
50. Boiko AN, Guseva ME, Guseva MA, et al. Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children. J Neurovirol 2000;6:S152-5.
51. Selcen D, Anlar B, Renda Y. Multiple sclerosis in childhood: report of 16 cases. Eur Neurol 1996;36:79-84.
52. Belopitova L, Guergueltcheva V, Bojinova V. Definite and suspected multiple sclerosis in children: long-term follow-up and magnetic resonance imaging findings. J Child Neurol 2001;16:317-24.
53. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
54. Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002;52:47-53.
55. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993;32:1764-9.
56. Visudhiphan P, Chiemchanya S, Santadusit S. Optic neuritis in children: recurrence and subsequent development of multiple sclerosis. Pediatr Neurol 1995;13:293-5.
57. Kriss A, Francis DA, Cuendet F, et al. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry 1988;51:1253-8.
58. Morales D, Siatkowski RM, Howard CW, Warman R. Optic neuritis in children. J Pediatr Ophthalmol Strabismus 2000;37:254-9.
59. Galetta SL. The controlled high risk Avonex multiple sclerosis trial. J Neuroophthalmol 2001;21:292-5.
60. Filippini G, Brusaferri F, Sibley WA, et al. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis (Cochrane Review). In: The Cochran Library. Issue 40. Oxford: Update Software; 2000.
61. Waubant E, Hietpas J, Stewart T, et al. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 2001;32:211-3.
62. Mikaeloff Y, Moreau T, Debouverie M, et al. Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr 2001;139:443-6.
63. Balassy CS, Bernert G, Wober-Bingol C, et al. Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis. Neuropediatrics 2001;32:28-37.
64. Jeffery DR, Mandler RN, Davis LE. Transverse myelitis: retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993;50:532-5.
65. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981;31:966-71.
66. Ropper AH, Poskanzer DC. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1978;4:51-9.
67. Scott T, Weikers N, Hospodar M, Wapenski J. Acute transverse myelitis: a retrospective study using magnetic resonance imaging. Can J Neurol Sci 1994;21:133-6.
68. Cheng W, Chiu RW, Tam PKH. Residual bladder dysfunction 2 to 10 years after acute transverse myelitis. J Paediatr Child Health 1999;35:476-8.
69. Dunne K, Hopkins IJ, Shield LK. Acute transverse myelopathy in childhood. Dev Med Child Neurol 1986;28:198-204.
70. Ganesan V, Borzyskowski M. Characteristics and course of urinary tract dysfunction after acute transverse myelitis in childhood. Dev Med Child Neurol 2001;43:473-5.
71. Paine RS, Byers RK. Transverse myelopathy in childhood. Am J Dis Child 1953;85:151-63.
72. Wilmshurst JM, Walker MC, Pohl KRE. Rapid onset transverse myelitis in adolescence: implications for pathogenesis and prognosis. Arch Dis Child 1999;80:137-42.
73. Scott TF, Bhagavatula K, Snyder PJ, Chieffe C. Transverse myelitis: comparison with spinal cord presentations of multiple sclerosis. Neurology 1998;50:429-33.
74. Garcia-Zozaya IA. Case report and review of the literature: acute transverse myelitis in a 7-month-old boy. J Spinal Cord Med 2001;24:114-8.
75. Sebire G, Hollenberg H, Meyer L, Huault G, Landrieu P, Tardieu M. High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child 1997;76:167-8.
76. Lahat E, Pillar G, Ravid S, Barzilai A, Etzioni A, Shaahar E. Rapid recovery from transverse myelopathy in children treated with methylprednisolone. Pediatr Neurol 1998;19:279-82.
77. Kalita J, Misra UK. Is methyl prednisolone useful in acute transverse myelitis? Spinal Cord 2001;39:471-6.
78. Riikonen R, Donner M, Erkkila H. Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children. Dev Med Child Neurol 1988;30:349-59.
79. Hierons R, Lyle TK. Bilateral retrobulbar optic neuritis. Brain 1959;82:56-67.
80. Farris BK, Pickard DJ. Bilateral postinfectious optic neuritis and intravenous steroid therapy in children. Ophthalmology 1990;97:339-45.
81. Kennedy C, Carroll FD. Optic neuritis in children. Ophthalmology 1960;63:747-55.
82. Good WV, Muci-Mendoza R, Berg BO, Frederick DR, Hoyt CS. Optic neuritis in children with poor recovery of vision. Aust N Z J Ophthalmol 1992;20:319-23.
83. Beck RW, Cleary PA. Optic neuritis treatment trial: one year follow-up results. Arch Ophthalmol 1993;111:773-5.